2 S. Wang, S. Penchala, S. Prabhu, J. Wang and Y. Huang, Curr. Drug
Discovery Technol., 2010, 7, 67–75.
3 T. Kumagai, C. I. Muller, J. C. Desmond, Y. Imai, D. Heber and H. P.
Koeffler, Leuk. Res., 2007, 31, 523–530.
4 M. Li-Weber, Cancer Treat. Rev., 2009, 35, 57–68.
5 J. Gao, W. A. Morgan, A. Sanchez-Medina and O. Corcoran, Toxicol.
Appl. Pharmacol., 2011, 254, 221–228.
6 F. L. Chan, H. L. Choi, Z. Y. Chen, P. S. Chan and Y. Huang, Cancer
Lett., 2000, 160, 219–228.
7 G. Du, G. Han, S. Zhang, H. Lin, X. Wu, M. Wang, L. Ji, L. Lu, L. Yu
and W. Liang, Eur. J. Pharmacol., 2010, 630, 121–130.
8 X. F. Xu, B. L. Cai, S. M. Guan, Y. Li, J. Z. Wu, Y. Wang and B. Liu,
Invest. New Drugs, 2011, 29, 637–645.
9 J. I. Chao, W. C. Su and H. F. Liu, Mol. Cancer Ther., 2007, 6, 3039–
3048.
10 H. Takahashi, M. C. Chen, H. Pham, E. Angst, J. C. King, J. Park, E.
Y. Brovman, H. Ishiguro, D. M. Harris, H. A. Reber, O. J. Hines, A. S.
Gukovskaya, V. L. Go and G. Eibl, Biochim. Biophys. Acta, 2011, 1813,
1465–1474.
11 D. G. Hardie, Nat. Rev. Mol. Cell Biol., 2007, 8, 774–785.
12 D. G. Hardie and K. Sakamoto, Physiology. (Bethesda.), 2006, 21,
48–60.
13 Vazquez-Martin, C. Oliveras-Ferraros, E. Lopez-Bonet and J. A.
Menendez, Cell Cycle, 2009, 8, 3679–3683.
14 S. Fogarty and D. G. Hardie, Biochim. Biophys. Acta, Proteins
Proteomics, 2010, 1804, 581–591.
15 Y. C. Tang, B. R. Williams, J. J. Siegel and A. Amon, Cell, 2011, 144,
499–512.
Fig. 4 The effect of compound 9 and AICAR on cell apoptosis measured
by Hoechst 33342 staining. A431 (left), SK-OV-3 (middle) and DU145
(right) cells were treated with 25 mM compound 9 or 1 mM AICAR for
48 h. Apoptotic cells with fragmented nuclei (arrows) are seen in the cells
treated with compound 9 (middle panel) or AICAR (bottom panel), but
not in the control cells (upper panel). Magnification, ¥400.
3. Conclusions
16 R. Rattan, S. Giri, A. K. Singh and I. Singh, J. Biol. Chem., 2005, 280,
39582–39593.
In conclusion, we prepared a number of novel baicalein derivatives
containing various alkyl and substituted benzyl groups. The
cytotoxicities of the synthetic baicalein derivatives were evaluated,
and two of the most potent synthetic compounds, 8 and 9, were
determined for their ability for activation of AMPK in A431,
SK-OV-3, DU 145 and HeLa cells. The results revealed that the
derivatives 8 and 9 were able to activate AMPK by enhancing
the levels of phosphorylated AMPKa in A431, SK-OV-3 and DU
145 cells, and particularly in LKB1-deficient HeLa cells, and the
compounds demonstrated more potent anti-proliferative effects
than baicalein and AICAR. Our findings in this study show
that activating AMPK by these novel baicalein derivatives might
be an alternative therapeutic approach to exert anti-proliferative
functions.
17 G. Z. Rocha, M. M. Dias, E. R. Ropelle, F. Osorio-Costa, F. A. Rossato,
A. E. Vercesi, M. J. Saad and J. B. Carvalheira, Clin. Cancer Res., 2011,
17, 3993–4005.
18 X. Tan, W. X. Yao, J. Ge, X. C. Peng, X. B. Du, R. Zhang, B. Yao, K.
Xie, L. H. Li, H. Dong, F. Gao, F. Zhao, J. M. Hou, J. M. Su and J. Y.
Liu, Cancer, 2011, DOI: 10.1002/cncr.26151.
19 S. Hadad, T. Iwamoto, L. Jordan, C. Purdie, S. Bray, L. Baker, G.
Jellema, S. Deharo, D. G. Hardie, L. Pusztai, S. Moulder-Thompson, J.
A. Dewar and A. M. Thompson, Breast Cancer Res. Treat., 2011, 128,
783–794.
20 J. T. Hwang, D. Y. Kwon and S. H. Yoon, New Biotechnol., 2009, 26,
17–22.
21 H. X. Guo, D. H. Liu, Y. Ma, J. F. Liu, Y. Wang, Z. Y. Du, X. Wang,
J. K. Shen and H. L. Peng, Acta Pharmacol. Sin., 2009, 30, 1505–
1512.
22 J. F. Liu, Y. Ma, Y. Wang, Z. Y. Du, J. K. Shen and H. L. Peng,
Phytother. Res., 2011, 25, 588–596.
23 Akao, K. Kawabata, E. Yanagisawa, K. Ishihara, Y. Mizuhara, Y.
Wakui, Y. Sakashita and K. Kobashi, J. Pharm. Pharmacol., 2000,
52, 1563–1568.
Author contributions
24 J. Y. Wu, K. T. Chung, Y. W. Liu, F. J. Lu, R. S. Tsai, C. H. Chen and
C. H. Chen, J. Agric. Food Chem., 2008, 56, 2838–2845.
25 Y. Lee, H. Yeo, S. H. Liu, Z. Jiang, R. M. Savizky, D. J. Austin and Y.
C. Cheng, J. Med. Chem., 2004, 47, 5555–5566.
26 G. Zapata-Torres, F. Opazo, C. Salgado, J. P. Munoz, H. Krautwurst,
C. Mascayano, S. Sepulveda-Boza, R. B. Maccioni and B. K. Cassels,
J. Nat. Prod., 2004, 67, 416–420.
Derong Ding and Baozi Zhang synthesized the compounds. Ying
Ma performed the experiments of cell apoptosis. Xin Wang
performed HPLC and HRMS analysis. Tao Meng, Hongli Peng
and Jingkang Shen co-wrote the paper. Hongli Peng and Jingkang
Shen supervised the research.
27 W. H. Huang, A. R. Lee and C. H. Yang, Biosci., Biotechnol., Biochem.,
2006, 70, 2371–2380.
28 K. Verma and R. Pratap, Nat. Prod. Rep., 2010, 27, 1571–1593.
29 P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica,
J. T. Warren, H. Bokesch, S. Kenney and M. R. Boyd, J. Natl. Cancer
Inst., 1990, 82, 1107–1112.
30 S. A. Hawley, J. Boudeau, J. L. Reid, K. J. Mustard, L. Udd,
T. P. Makela, D. R. Alessi and D. G. Hardie, J. Biol., 2003, 2,
28.
Acknowledgements
This work was supported by the National Natural Science
Foundation of China (81172921), and 863 Program (the National
High Technology Research and Development Program of China,
No. 2007AA02Z308). We would like to thank Zhiyan Du and Ying
Wang for skilful technical.
31 X. Hou, S. Xu, K. A. Maitland-Toolan, K. Sato, B. Jiang, Y. Ido, F.
Lan, K. Walsh, M. Wierzbicki, T. J. Verbeuren, R. A. Cohen and M.
Zang, J. Biol. Chem., 2008, 283, 20015–20026.
Notes and references
32 S. Y. Yu, D. W. Chan, V. W. Liu and H. Y. Ngan, Tumor Biol., 2009, 30,
80–85.
1 P. Parajuli, N. Joshee, A. M. Rimando, S. Mittal and A. K. Yadav,
Planta Med., 2009, 75, 41–48.
This journal is
The Royal Society of Chemistry 2011
Org. Biomol. Chem., 2011, 9, 7287–7291 | 7291
©